July 24, 2019
Immix gets FDA’s green light to expand trial for cancer combination therapy
Immix Biopharma, said Tuesday it got a letter from the FDA authorizing it to expand its phase 1b/2a clinical trial of…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Immix Biopharma